TITLE

Emerging treatment combinations: Integrating therapy into clinical practice

AUTHOR(S)
Wong, Serena T.
PUB. DATE
December 2009
SOURCE
American Journal of Health-System Pharmacy;12/2/2009, Issue S6, pS9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses research regarding combination drug treatments for metastatic breast cancer. Signal-transduction pathways play a key role in the development of breast cancer and medical research has been focusing on immunosuppressant agents such as everolimus. Epidermal growth factor receptor (EGFR) has been studied to determine its role in resistance to endocrine therapy, as well as the role of epigenetic gene silencing in modifying the expression of tumor-suppressing genes.
ACCESSION #
47627663

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics